Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BCHE | P06276 | 1/20 | 0.37 |
| ▸ | ACHE | P22303 | 1/20 | 0.37 |
| ▸ | MAOA | P21397 | 1/20 | 0.37 |
| ▸ | MAOB | P27338 | 1/20 | 0.37 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.37 |
| ▸ | GABRA1 | P14867 | 1/20 | 0.36 |
| ▸ | GABRB2 | P47870 | 1/20 | 0.36 |
| ▸ | TAAR1 | Q96RJ0 | 2/20 | 0.36 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.36 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.36 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.36 |
| ▸ | PRMT1 | Q99873 | 1/20 | 0.35 |
| ▸ | HTR2A | P28223 | 1/20 | 0.35 |
| ▸ | HTR2C | P28335 | 1/20 | 0.35 |
| ▸ | HTR2B | P41595 | 1/20 | 0.35 |
| ▸ | MEN1 | O00255 | 1/20 | 0.35 |
| ▸ | USP2 | O75604 | 1/20 | 0.35 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22834295 | 1.00 | BCHE (0.37) | BCHEACHEMAOAMAOBL3MBTL1 | |
| SCHEMBL20052471 | 0.80 | BCHE (0.40) | BCHEACHEL3MBTL1TAAR1SLC6A2 | |
| SCHEMBL1241287 | 0.80 | TP53 (0.36) | BCHEACHEMAOAMAOBL3MBTL1 | |
| SCHEMBL25883003 | 0.79 | AHR (0.44) | BCHEACHEGABRA1GABRB2TAAR1 | |
| SCHEMBL29797921 | 0.76 | MAOA (0.58) | MAOAMAOBL3MBTL1MEN1USP2 | |
| SCHEMBL436702 | 0.76 | MAOA (0.58) | MAOAMAOBL3MBTL1MEN1USP2 | |
| SCHEMBL7509519 | 0.76 | GABRA1 (0.40) | MAOAMAOBL3MBTL1GABRA1GABRB2 | |
| SCHEMBL12205445 | 0.74 | KMT2A (0.46) | MAOAMAOBL3MBTL1MEN1USP2 | |
| SCHEMBL31545095 | 0.72 | MEN1 (0.48) | MAOAMAOBMEN1USP2KMT2A | |
| SCHEMBL21117870 | 0.72 | KDM4E (0.51) | BCHEACHEGABRA1GABRB2TAAR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0971731-A1 | SUPPRESSION OF MALIGNANCY UTILIZING RIBONUCLEOTIDE REDUCTASE R1 | Genesense Technologies, Inc. (CA) | 2000-01-19 | — | — | EP | disclosed |
| WO-1998037878-A9 | METHODS AND COMPOSITIONS FOR TREATING CYSTIC FIBROSIS | — | 1999-02-11 | — | — | WO | disclosed |
| WO-1998041231-A1 | SUPPRESSION OF MALIGNANCY UTILIZING RIBONUCLEOTIDE REDUCTASE R1 | GENESENSE TECHNOLOGIES, INC. (CA) | 1998-09-24 | — | — | WO | disclosed |
| WO-1998037878-A1 | METHODS AND COMPOSITIONS FOR TREATING CYSTIC FIBROSIS | GENZYME CORPORATION (US) | 1998-09-03 | — | — | WO | disclosed |
| EP-0659211-A4 | METHODS AND THERAPEUTIC COMPOSITIONS FOR TREATING CYSTIC FIBROSIS. | GENZYME CORP (US) | 1996-02-07 | — | — | EP | disclosed |
| EP-0659211-A1 | METHODS AND THERAPEUTIC COMPOSITIONS FOR TREATING CYSTIC FIBROSIS | GENZYME CORPORATION (US) | 1995-06-28 | — | — | EP | disclosed |
| WO-1994004671-A1 | METHODS AND THERAPEUTIC COMPOSITIONS FOR TREATING CYSTIC FIBROSIS | GENZYME CORPORATION (US) | 1994-03-03 | — | — | WO | disclosed |